← Back to Search

Behavioral Intervention

MI-CARE Team Model for Hypertension (MI-CARE Trial)

N/A

Recruiting

Led By Jeannie K Lee, PharmD

Research Sponsored by University of Arizona

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18 years

Have medication-treated hypertension

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 6

Awards & highlights

MI-CARE Trial Summary

This trial provides an interprofessional team care model to improve medication adherence and reduce hypertension disparities in high-risk populations.

Who is the study for?

This trial is for adults over 18 who identify as African-American, Latino, or Vietnamese and speak English, Spanish, or Vietnamese. They must have high blood pressure treated with medication, use 5 or more chronic medications and have less than 80% adherence to their hypertension medication.Check my eligibility

What is being tested?

The MI-CARE program is being tested; it's a coordinated care team approach designed to improve how well patients stick to their blood pressure medication regimen by providing comprehensive primary care through an interprofessional team.See study design

What are the potential side effects?

Since this trial focuses on improving medication adherence using a care team approach rather than testing new drugs, specific side effects are not listed. However, general risks may include potential discomfort from increased monitoring.

MI-CARE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am taking medication for high blood pressure.

Select...

I often forget to take my blood pressure medication.

Select...

I take 5 or more medications regularly for chronic conditions.

MI-CARE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Blood Pressure

Objectively measured medication adherence (pill count)

Self-reported medication adherence (survey)

Secondary outcome measures

Body Mass Index (BMI)

HgbA1c

Lipid

+2 more

MI-CARE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MI-CARE InterventionExperimental Treatment1 Intervention

Pharmacist-community health worker team providing coordinated care tailored to high-risk patients with hypertension. MI-CARE intervention participants will meet with the pharmacist-CHW team for medication optimization and tailored case management. Pill counts will be completed to assess adherence and BP will be measured at each visit to guide antihypertensive medication optimization and provide feedback to participants about their adherence and BP control. Intervention visits will be followed by a booster one month later.

Group II: Waitlist ControlActive Control1 Intervention

Participants enrolled in this arm will receive usual medical care

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Massachusetts, AmherstOTHER

78 Previous Clinical Trials

467,322 Total Patients Enrolled

University of ArizonaLead Sponsor

515 Previous Clinical Trials

148,264 Total Patients Enrolled

Jeannie K Lee, PharmDPrincipal InvestigatorUniversity of Arizona College of Pharmacy

1 Previous Clinical Trials

10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open now for this research project?

"According to the information on clinicaltrials.gov, this trial has opened its doors to potential participants. The initial post was published on August 15th 2023 and it was most recently edited on September 6th of that same year."

Answered by AI

What is the total number of individuals participating in this research endeavor?

"Affirmative. According to clinicaltrials.gov, this study is actively recruiting volunteers and was first posted on August 15th 2023 with the latest edit made on September 6th 2023. 450 people need to be admitted at one specified location for participation in the trial."

Answered by AI

What aims are being sought after by this research endeavor?

"The purpose of this 6 month trial is to assess self-reported adherence to the prescribed medication. Secondary metrics, such as statin use and lipid levels for those with dyslipidemia or a risk factor greater than 7.5%, will be taken from electronic health records along with HgbA1c measurements for participants who have diabetes."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

My Interprofessional Care Team for Adherence and Research Engagement Disparities

2023. "My Interprofessional Care Team for Adherence and Research Engagement Disparities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05470439.